Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease 1.0
Free Version
Publisher Description
Triglyceride-rich lipoproteins and high-density lipoprotein in cardiometabolic disease: Therapeutics old and new - M. John Chapman and Henry N. Ginsberg on behalf of the EAS Consensus Panel. Elevated triglyceride-rich lipoproteins (TRL), for which triglycerides are a marker, and low plasma concentrations of high-density lipoprotein cholesterol (HDL-C), often referred to as atherogenic dyslipidaemia, is a common risk factor for cardiometabolic disease, even among individuals who achieve target level of low-density lipoprotein cholesterol (LDL-C). Both are also key components of the metabolic syndrome, a pre-diabetic state. Atherogenic dyslipidaemia is also a key driver of cardiovascular risk in individuals with metabolic syndrome or diabetes. The 2011 ESC/EAS Guidelines for Management of Dyslipidaemia include recommendations for the management of elevated triglycerides and/or low HDL-C after achievement of LDL-C goals. Despite this, management is still far from optimal. This Handbook authored by Professors Chapman and Ginsberg on behalf of the European Atherosclerosis Society Consensus Panel, provides a unique accessible reference for clinicians. The Handbook provides a comprehensive background to HDL and TRL, and their relevance to cardiometabolic disease, and addresses the ongoing controversies surrounding HDL biology and its clinical relevance. Recommendations for clinical management of atherogenic dyslipidaemia are discussed in the context of the recent ESC/EAS Guidelines for Management of Dyslipidaemia. The Handbook deals with practical issues in measurement, provides recommendations for treatment, and discusses emerging novel therapies. Case reports are a key feature to guide clinicians in their routine practice.
Requires iOS 7.0 or later. Compatible with iPhone, iPad, and iPod touch.
About Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease
Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease is a free app for iOS published in the Health & Nutrition list of apps, part of Home & Hobby.
The company that develops Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease is Abannan (UK) Limited. The latest version released by its developer is 1.0.
To install Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease on your iOS device, just click the green Continue To App button above to start the installation process. The app is listed on our website since 2014-11-21 and was downloaded 0 times. We have already checked if the download link is safe, however for your own protection we recommend that you scan the downloaded app with your antivirus. Your antivirus may detect the Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease as malware if the download link is broken.
How to install Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease on your iOS device:
- Click on the Continue To App button on our website. This will redirect you to the App Store.
- Once the Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease is shown in the iTunes listing of your iOS device, you can start its download and installation. Tap on the GET button to the right of the app to start downloading it.
- If you are not logged-in the iOS appstore app, you'll be prompted for your your Apple ID and/or password.
- After Triglyceride-rich lipoproteins & high-density lipoprotein in cardiometabolic disease is downloaded, you'll see an INSTALL button to the right. Tap on it to start the actual installation of the iOS app.
- Once installation is finished you can tap on the OPEN button to start it. Its icon will also be added to your device home screen.
